Skip to content
  • Lab Home
  • Research
  • People
    • Lab Members
    • Alumni
  • Publications
  • News
  • Contact
Donate to ISB
clear

News

Postdoc Journey Video

Posted: February 10, 2026

Philanthropy Baliga Lab Fellows
Behind the Breakthroughs: ISB’s Postdoctoral Fellows in Focus

Behind the Breakthroughs: ISB’s Postdoctoral Fellows in Focus

Postdoctoral fellows are the lifeblood of research institutions, yet their contributions are often underrecognized. At the Institute for Systems Biology (ISB), postdocs enter the scientific workforce with passion, vision, and advanced training – bringing the fresh ideas that fuel discovery.

Behind the Breakthroughs: ISB’s Postdoctoral Fellows in Focus
Behind the Breakthroughs: ISB’s Postdoctoral Fellows in Focus
Diagram showing a cycle of precision health data. On the left, a user is surrounded by a "Dense, Dynamic Data Cloud" including Wearables, Omics, Exposome, and EHRs. Arrows point to "Longitudinal Data" tracking personal baselines over a lifespan. This feeds into "AI Models" for pattern detection, which outputs "Actionable Possibilities" for personalized recommendations, pointing back to the user.

Posted: January 26, 2026

Chronic Illness Press Release Advancing Health
AI-Era Early Detection Is Shifting Healthcare from Reactive to Proactive

AI-Era Early Detection Is Shifting Healthcare from Reactive to Proactive

Researchers at the Institute for Systems Biology argue that combining systems biology, longitudinal multiomics data, and artificial intelligence could transform healthcare from reactive treatment to proactive prevention, enabling scientists and clinicians to detect early molecular signs of disease and intervene before symptoms appear.

AI-Era Early Detection Is Shifting Healthcare from Reactive to Proactive
AI-Era Early Detection Is Shifting Healthcare from Reactive to Proactive

More News (Neurological Disorders)

 

Posted: June 13, 2023

Brain Health Healthspan and Longevity Hood Lab
New Alzheimer’s drugs are costly and controversial. Are we going about this all wrong?

New Alzheimer’s drugs are costly and controversial. Are we going about this all wrong?

There is tremendous market and media frenzy around new Alzheimer’s disease drugs, but their efficacy is contested while the potential of prevention is untapped and underreported, Drs. Lee Hood and Nathan Price wrote in an opinion piece published by the Los Angeles Times.

New Alzheimer’s drugs are costly and controversial. Are we going about this all wrong?
New Alzheimer’s drugs are costly and controversial. Are we going about this all wrong?
soldier

Posted: February 14, 2020

Chronic Illness Hood Lab Neurological Disorders
ISB Researchers Seek a Better Way to Identify Chronic Mild Traumatic Brain Injury

ISB Researchers Seek a Better Way to Identify Chronic Mild Traumatic Brain Injury

Mild traumatic brain injury (mTBI) has been a frequent injury among U.S. combatants, and blast-related mTBI has been called the “signature injury” from military conflicts in Iraq and Afghanistan. ISB researchers are working to develop new methods to identify molecular changes in the blood of war veterans diagnosed with chronic mTBI.

ISB Researchers Seek a Better Way to Identify Chronic Mild Traumatic Brain Injury
ISB Researchers Seek a Better Way to Identify Chronic Mild Traumatic Brain Injury
View All News
  • Research
    • Research
  • People
    • People
    • Alumni
  • Publications
    • Publications
  • News
    • News
  • Contact
    • Contact
ISB logo (1-color)
Donate to ISB Contact ISB

Subscribe to Molecular Me, where we share news of our transformational research, devoted scientists and educators, upcoming events, and more.

© 2026 Hood Lab. All Rights Reserved
  • Login
  • Intranet